AbbVie (ABBV) Net Income towards Common Stockholders (2012 - 2026)
AbbVie (ABBV) posted Net Income towards Common Stockholders of $4.22 billion for Q3 2026, compared with $186 million a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income towards Common Stockholders at AbbVie was $10.34 billion, up 333.1% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.
- Annual Net Income towards Common Stockholders has declined for three consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- In prior years, AbbVie's Net Income towards Common Stockholders was $4.28 billion in FY2024 (-12.0%), $4.86 billion in FY2023 (-58.9%), $11.84 billion in FY2022 (+2.5%) and $11.54 billion in FY2021 (+150.0%).
- The Q3 2026 figure stands as the highest quarterly Net Income towards Common Stockholders since Q1 2022.
- On a year-over-year basis, Net Income towards Common Stockholders increased in 1 of the last five quarters, with growth averaging 22.7%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q1 2024, with growth of 472.8%; the weakest was Q1 2023, with a decline of 94.7%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $3.61 billion (Q2 2026), $695 million (Q1 2026) and $1.82 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.22 Bn |
| Jun 30, 2026 | 3.61 Bn |
| Mar 31, 2026 | 695.00 Mn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 186.00 Mn |
| Jun 30, 2025 | 938.00 Mn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 822.00 Mn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 239.00 Mn |
| Dec 31, 2022 | 2.47 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 924.00 Mn |
| Mar 31, 2022 | 4.49 Bn |
| Dec 31, 2021 | 4.04 Bn |
API Access
AbbVie Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();